Literature DB >> 9726727

Blastomycosis in northeast Tennessee.

J E Vasquez1, J B Mehta, R Agrawal, F A Sarubbi.   

Abstract

STUDY
OBJECTIVES: To study the epidemiologic and clinical features of blastomycosis in northeast Tennessee.
DESIGN: Retrospective review of blastomycosis cases in the region from 1980 through 1995.
SETTING: Hospitals located in the Tri-Cities region of northeast Tennessee. PATIENTS: Seventy-two patients with confirmed blastomycosis infection.
INTERVENTIONS: None.
RESULTS: During the 1980 to 1995 study period, we documented 72 cases of blastomycosis. The mean age was 52 years (range, 13 to 86 years), most were male (69.4%), and nine were immunocompromised. A possible environmental exposure was noted for 28 patients. Pulmonary involvement represented the most common site of infection (61 cases), but multiorgan involvement was common (17 cases). Most patients with pulmonary blastomycosis (66%) presented with a chronic illness, and radiologic findings usually revealed local consolidation or a mass-like lesion. Nine patients developed ARDS with an associated mortality rate of 89%, compared with a 10% mortality for non-ARDS pulmonary cases. Antifungal treatment regimens varied widely, with amphotericin B often used for sicker patients. An epidemiologic evaluation revealed that the mean yearly incidence rate for blastomycosis quadrupled between 1980 and 1987 (0.31 cases/ 100,000 population) and 1988 to 1995 (1.23 cases/100,000 population) (p=0.00001). Most new blastomycosis cases in the 1988 to 1995 period occurred in three counties in the region where significant new construction projects have been underway.
CONCLUSION: Blastomycosis is endemic in northeast Tennessee and the number of cases is increasing, coinciding with major new construction in the region. Clinicians in the area must be alert to this condition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726727     DOI: 10.1378/chest.114.2.436

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  Antigen assay with the potential to aid in diagnosis of blastomycosis.

Authors:  Michelle Durkin; John Witt; Ann Lemonte; Blair Wheat; Patricia Connolly
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Primary cutaneous blastomycosis as a cause of acute respiratory distress syndrom: case report and literature review.

Authors:  Jason J Emer; Joel B Spear
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

3.  Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds.

Authors:  Dennis J Baumgardner; Erica M Knavel; Dale Steber; Geoffrey R Swain
Journal:  Mycopathologia       Date:  2006-05       Impact factor: 2.574

Review 4.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  The differential diagnosis of pulmonary blastomycosis using case vignettes: a Wisconsin Network for Health Research (WiNHR) study.

Authors:  Dennis J Baumgardner; Jonathan L Temte; Erin Gutowski; William A Agger; Howard Bailey; James K Burmester; Indrani Banerjee
Journal:  WMJ       Date:  2011-04

Review 6.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

7.  Blastomycosis in indoor cats: suburban Chicago, Illinois, USA.

Authors:  Nancy Blondin; Dennis J Baumgardner; George E Moore; Lawrence T Glickman
Journal:  Mycopathologia       Date:  2007-01-29       Impact factor: 2.574

8.  Systemic blastomycosis diagnosed by prostate needle biopsy.

Authors:  Peter M Neal; Anne Nikolai
Journal:  Clin Med Res       Date:  2008-05

9.  Clinical characteristics and outcomes in patients with pulmonary blastomycosis.

Authors:  Doug Kralt; Bruce Light; Mary Cheang; Tracy MacNair; Lyle Wiebe; Bill Limerick; Pete Sarsfield; Greg Hammond; Kerry MacDonald; Elly Trepman; John M Embil
Journal:  Mycopathologia       Date:  2008-10-19       Impact factor: 2.574

Review 10.  Clinical Manifestations and Treatment of Blastomycosis.

Authors:  Joseph A McBride; Gregory M Gauthier; Bruce S Klein
Journal:  Clin Chest Med       Date:  2017-06-12       Impact factor: 4.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.